Vaxcyte (PCVX) Cash from Financing (Quarterly): 5.701M

Vaxcyte, Inc. (PCVX)

71.38 +6.36 (+9.79%) USD | NASDAQ | Oct 09, 16:00

71.27 -0.11 (-0.15%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2019. Start Trial.

Date	Value
June 30, 2026	5.701M
March 31, 2026	601.58M
December 31, 2025	2.408M
September 30, 2025	-3.671M
June 30, 2025	2.518M
March 31, 2025	0.759M
December 31, 2024	4.907M
September 30, 2024	1.515B
June 30, 2024	110.37M
March 31, 2024	818.20M
December 31, 2023	2.735M
September 30, 2023	48.55M
June 30, 2023	546.97M
March 31, 2023	41.56M
December 31, 2022	656.63M

Date	Value
September 30, 2022	44.02M
June 30, 2022	49.88M
March 31, 2022	111.02M
December 31, 2021	8.754M
September 30, 2021	7.599M
June 30, 2021	0.956M
March 31, 2021	0.487M
December 31, 2020	0.555M
September 30, 2020	0.036M
June 30, 2020	264.38M
March 31, 2020	109.90M
December 31, 2019	42.45M
September 30, 2019	0.368M
June 30, 2019	-0.077M
March 31, 2019	-0.076M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks